We are thrilled to share the updated Exceptional Reviewers List 2024. This program was designed to recognize and honor scholars who have consistently delivered exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Cancers (ISSN: 2072-6694) recognizes the significant role our reviewers play in maintaining the quality and integrity of the articles we publish. According to recent surveys conducted in 2023, 91% of our authors rate the peer review as good or excellent, thanks to our pool of excellent reviewers.
We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in the Cancers’ peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable.
The Exceptional Reviewers List was introduced in April 2024. Each quarter, we will be selecting a group of outstanding reviewers and will introduce them here.
Q1
Name: Dr. Muhammad Kibriya
Affiliation: Institute for Population and Precision Health (IPPH), Biological Sciences Division, University of Chicago, Chicago, IL, USA
Interests: colorectal carcinoma; microsatellite instability; cytogenetics; molecular genomics; GWAS; copy number change; telomere; methylation; liquid biopsy
Name: Dr. Matthias Nees
Affiliation: Department of Biochemistry and Molecular Biology, Medical University in Lublin, Lublin, Poland
Interests: organotypic culture; tumor/stroma interactions; 3D models; extracellular matrix (ECM); tumour microenvironment (TME); epithelial-to-mesenchymal transition (EMT); automated image analyses; phenotypic screening; personalized medicine
Name: Dr. Laura Casalino
Affiliation: Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, Consiglio Nazionale dele Ricerche (CNR), Naples, Italy
Interests: cell differentiation; development; stem cells; transcription factors; epigenetics
Name: Dr. Antonella Argentiero
Affiliation: Medical Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Bari, Italy
Interests: pancreatic cancer; pancreatic ductal adenocarcinoma; tumor microenvironment
Name: Dr. John T. Lucas, Jr.
Affiliation: St. Jude Children’s Research Hospital, Memphis, TN, USA
Interests: neuroblastoma; high grade glioma; proteomics; clinical trial design/methodology
